Skip to content

Amsterdam workshop on scaling up treatment (meeting report)

Younger HIV patients at increased risk of heart disease

No link found between undetectable HIV viral load and unsafe sex in Swiss cohort

Women have larger increase in CD4 cell count after six months of HAART, but no racial differences

Abacavir/3TC/tenofovir study stopped due to high failure rate

Drug resistant HIV found in 10% of untreated Europeans

Alternating drug regimens may delay HIV treatment failure

Formula feed is `medicine to prevent HIV`

Kaletra: could upping the dose overcome resistance?